Lipoprotein(a): the underutilized risk factor for cardiovascular disease

Authors

  • T Z Khan Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom
  • S R Bornstein University Hospital Carl Gustav Carus, Fetscher Street 74, Dresden 01307, Germany
  • M Barbir Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom

DOI:

https://doi.org/10.21542/gcsp.2019.11

Abstract

Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing evidence suggesting that lowering Lp(a) may reduce the risk of cardiovascular events and ameliorate symptoms.

Downloads

Published

2019-05-26

Issue

Vol. 2019 No. 2 (2019)

Section

News and views

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.